Traditional AMPA receptor antagonists partially block Nav1.6-mediated persistent current

Neuropharmacology

Volumn 55, Issue 7, 2008, Pages 1165-1171

  Welch, N C ^a   Lin, W ^b   Juranka, P F ^b   Morris, C E ^b   Stys, P K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

1 Naphthylacetyl spermine; CP465022; GYKI52466; Nav1.6; Persistent; SYM2206

Indexed keywords

1 NAPHTHYLACETYL SPERMINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; CP 465022; GYK 152466; SODIUM CHANNEL; SODIUM CHANNEL NAV1.6; SYM 2206; TETRODOTOXIN; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; PATCH CLAMP; PRIORITY JOURNAL; SODIUM CURRENT;

ANESTHETICS, LOCAL; CELL LINE; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; RECEPTORS, AMPA; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TETRODOTOXIN;

EID: 54049133605     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.07.015     Document Type: Article

References (37)

1. Alberdi E., Sánchez-Gomez M.V., Marino A., and Matute C. Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiology of Disease 9 (2002) 234-243
2. Boiko T., Rasband M.N., Levinson S.R., Caldwell J.H., Mandel G., Trimmer J.S., and Matthews G. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 30 (2001) 91-104
3. V1.6 voltage-gated sodium channel from human brain. Molecular Brain Research 103 (2002) 80-90
4. V1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 5616-5620
5. V1.6 sodium channels and Na/Ca exchanger. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 8168-8173
6. Donevan S.D., and Rogawski M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10 (1993) 51-59
7. Dubois J.M., and Bergman C. Late sodium current in the node of Ranvier. Pflugers Archiv: European Journal of Physiology 357 (1975) 145-148
8. Goldin A.L. Diversity of mammalian voltage-gated sodium channels. Annals of the New York Academy of Sciences 868 (1999) 38-50
9. Goldin A.L., Barchi R.L., Caldwell J.H., Hofmann F., Howe J.R., Hunter J.C., Kallen R.G., Mandel G., Meisler M.H., Metter Y.B., Noda M., Tamkun M.M., Waxman S.G., Wood J.N., and Catterall W.A. Nomenclature of voltage-gated sodium channels. Neuron 28 (2000) 365-368
10. Harvey P.J., Li X., Li Y., and Bennett D.J. Endogenous monoamine receptor activation is essential for enabling persistent sodium currents and repetitive firing in rat spinal motoneurons. Journal of Neurophysiology 96 (2006) 1171-1186
11. Hille B. Ion Channels of Excitable Membranes. third ed. (2001), Sinauer Associates, Inc., Sunderland, MA
12. Iino M., Koike M., Isa T., and Ozawa S. Voltage-sensitive blockage of Ca(2+)-permeable AMPA receptors by Joro spider toxin in cultured rat hippocampal neurones. Journal of Physiology 496 (1996) 431-437
13. Koike M., Iino M., and Ozawa S. Blocking effect of 1-naphthyl acetyl spermine on Ca(2+) permeable AMPA receptors in cultured rat hippocampal neurons. Neuroscience Research 29 (1997) 27-36
14. Lazzare J.T., Paternain A.V., Lerma J., Chenard B.L., Ewing F.E., Huang J., Welch W.M., Ganong A.H., and Menniti E.S. Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist. Neuropharmacology 42 (2002) 143-153
15. Li S., Mealing G.R., Morley P., and Stys P.K. Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na-dependent glutamate transport. Journal of Neuroscience 19 RC16 (1999) 1-9
16. Li S., and Stys P.K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. Journal of Neuroscience 20 (2000) 1190-1198
17. Li S., and Stys P.K. Na-K-ATPase inhibition and depolarization induce glutamate release via reverse Na-dependent transport in spinal cord white matter. Neuroscience 107 (2001) 675-683
18. Lynch J.L., Yu S.P., Canzoniero L.M.T., Sensi S.L., and Choi D.W. Sodium channel blockers reduce oxygen-glucose deprivation-induced cortical neuronal injury when combined with glutamate receptor antagonists. Journal of Pharmacology and Experimental Therapeutics 273 (1995) 554-560
19. Matute C., Domercq M., and Sánchez-Gómez M.V. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53 (2006) 212-224
20. Maurice N., Tkatch T., Meisler M., Sprunger L.K., and Surmeier D.J. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. Journal of Neuroscience 21 (2001) 2268-2277
21. McCarran W.J., and Goldberg M.P. White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated. Journal of Neuroscience 27 (2007) 4220-4229
22. McCracken E., Fowler J.H., Dewar D., Morrison S., and McCulloch J. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor SPD 502. Journal of Cerebral Blood Flow & Metabolism 22 (2002) 1090-1097
23. Pelletier J.C., Hesson D.P., Jones K.A., and Costa A.M. Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. Journal of Medicinal Chemistry 39 (1996) 343-346
24. Sánchez-Gomez M.V., and Matute C. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiology of Disease 6 (1999) 475-485
25. Smith M.R., Smith R.D., Plummer N.W., Meisler M.H., and Goldin A.L. Functional analysis of the mouse Scn8a sodium channel. Journal of Neuroscience 18 (1998) 6093-6102
26. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., and Honoré T. 2,3-Dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247 (1990) 571-574
27. Stys P.K. White matter injury mechanisms. Current Molecular Medicine 4 (2004) 109-126
28. Stys P.K., Sontheimer H., Ransom B.R., and Waxman S.G. Noninactivating, tetrodotoxin-sensitive Na conductance in rat optic nerve axons. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 6976-6980
29. Stys P.K., Waxman S.G., and Ransom B.R. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. Journal of Neurophysiology 67 (1992) 236-240
30. Stys P.K., Waxman S.G., and Ransom B.R. Ionic mechanisms of axonic injury in mammalian CNS white matter: role of Na channels and Na-Ca exchanger. Journal of Neuroscience 12 (1992) 430-439
31. + channels as targets for neuroprotective drugs. Trends in Pharmacological Sciences 16 (1995) 309-316
32. Tekkök S.B., and Goldberg M.P. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. Journal of Neuroscience 21 (2001) 4237-4248
33. Tekkök S.B., Ye Z., and Ransom B.R. Excitotoxic mechanisms of ischemic injury in myelinated white matter. Journal of Cerebral Blood Flow & Metabolism 27 (2007) 1540-1552
34. + channel in central neurons. Neuron 3 (1989) 695-704
35. Wilding T.J., and Huettner J.E. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors. Molecular Pharmacology 49 (1996) 540-546
36. Yoshioki A., Bacskai B., and Pleasure D. Pathophysiology of oligodendroglial excitotoxicity. Journal of Neuroscience Research 46 (1996) 427-437
37. v1.6 sodium channel. Biophysical Journal 87 (2004) 3862-3872